Day: 14. May 2013

Astellas Pharma reshapes research framework, to use more external resources

Among several items, Astellas will establish an Innovation Management (AIM) and scale back US subsidiaries, including refocusing of Astellas US Research Institute and closure of OSI Pharmaceuticals and Perseid Therapeutics. In-house fermentation research will be stopped, and the Kashima facility in Osaka will be closed (scheduled during FY2015). Multiple functions of the Kashima facility will […]

Fuji Oil has achieved top sales of “Soybean Renaissance”, a soybean milk cream.

The low-fat product is prepared by a new soybean separation fraction technology of FUJI OIL patented last year. Based on this “USS process” (for “ultra soy separation”), a soybean is fractionated into low-fat soybean milk” and “soybean milk cream”. In FY 2012, Fuji Oil doubled production capacity and reached sales of 1.500 t.” Fuji Oil […]

University of Tokyo group produces hematopoietic stem cells from human iPS cells

The team of Professor Hiromitsu NAKAUCHI at Tokyo University’s Institute of Medical Science achieved the In vitro generation of hematopoietic stem cells (HSCs) from induced pluripotent stem cells (iPSCs), opening a potential to provide novel therapeutic approaches for replacing bone marrow (BM) transplantation without rejection or graft versus host disease. When the HSCs were transplanteid […]

Scroll to top